Investor Conference Call - Clinical Trial Results
Release Date: 22/06/2010 12:00am
Pharmaxis Ltd expects to complete its analysis and announce the results of its second international Phase III clinical trial of Bronchitol in patients with cystic fibrosis prior to the end of today, 22 June 2010. The announcement will have the effect of lifting the current trading halt over the company's shares.
Categories: News and Media